The clinical benefit of β blockade has been proven in a variety of pathologic settings, including hypertension, angina pectoris, acute- and post-myocardial infarction, and congestive heart failure.

Mar. 27, 2025 — A research team has investigated structural changes in kidneys of patients with hypertension and type 2 diabetes. The results show that high blood pressure can lead to ...

Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this ...

Participants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement as early as 4 weeks of lorundrostat use. Safety concerns of lorundrostat ...

Welcome to the 2025 USC Men's Basketball Transfer Portal Tracker. Here you will find rolling live updates in timeline format as each transfer and declaration event happens (both exiting and incoming).

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

A study out last year in The Lancet Public Health listed hypertension as the leading dementia risk factor. The report, which reflected on 27 studies about people with dementia around the world ...

Hypothyroidism has been recognized as a cause of secondary hypertension. Previous studies on the prevalence of hypertension in subjects with hypothyroidism have demonstrated elevated blood ...

Xiang-Qun Hu https://orcid.org/0000-0003-1626-9541 Lawrence D. Longo, MD Center for Perinatal Biology, Department of Basic Sciences, Loma Linda University School of ...

Angiotensin II causes narrowing of blood vessels and fluid retention. This can lead to hypertension. ACE inhibitors help prevent heart failure by reducing blood pressure and fluid retention. If you ...